Skip to main content
. Author manuscript; available in PMC: 2020 Aug 7.
Published in final edited form as: Prog Mol Biol Transl Sci. 2019 Aug 7;168:277–287. doi: 10.1016/bs.pmbts.2019.07.010

Fig. 1.

Fig. 1

TTR and its ligands. (A) Schematic structures of the thyroid hormone, thyroxine, a natural ligand of TTR, and of the TTR ligands tafamidis, an FDA-approved drug for FAP, diflunisal, available off-label for TTR amyloidoses, and AG10, a compound in clinical trial for FAC. (B) A ribbon diagram of TTR showing the tetramer structure composed of yellow, red, blue, and green monomers.